These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10434609)

  • 1. [Cervical dystonia (spasmodic torticollis)].
    Nomoto M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):122-7. PubMed ID: 10434609
    [No Abstract]   [Full Text] [Related]  

  • 2. Dystonia in a patient with ring chromosome 21.
    Hou CE; Schlaggar BL; Racette BA
    Mov Disord; 2003 Dec; 18(12):1547-9. PubMed ID: 14673898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peri-operative treatment with botulinum A toxin prior to posterior cervical decompression in a case with cervical spondylosis caused by spasmodic torticollis secondary to cerebral palsy].
    Iwamuro H; Takahashi H; Ide K; Nakauchi J; Taniguchi M
    No Shinkei Geka; 2003 Sep; 31(9):1015-20. PubMed ID: 14513786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical dystonia presenting as a phenocopy in an Irish SCA2 family.
    Walsh R; O'Dwyer JP; O'Riordan S; Bradley D; Moroney J; Hutchinson M
    Mov Disord; 2009 Feb; 24(3):466-7. PubMed ID: 19086087
    [No Abstract]   [Full Text] [Related]  

  • 5. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Ondo WG; Gollomp S; Galvez-Jimenez N
    Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep brain stimulation for generalised dystonia and spasmodic torticollis.
    Bittar RG; Yianni J; Wang S; Liu X; Nandi D; Joint C; Scott R; Bain PG; Gregory R; Stein J; Aziz TZ
    J Clin Neurosci; 2005 Jan; 12(1):12-6. PubMed ID: 15639404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.
    Cano SJ; Hobart JC; Edwards M; Fitzpatrick R; Bhatia K; Thompson AJ; Warner TT
    Neurology; 2006 Dec; 67(12):2230-2. PubMed ID: 17190951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
    Truong D; Duane DD; Jankovic J; Singer C; Seeberger LC; Comella CL; Lew MF; Rodnitzky RL; Danisi FO; Sutton JP; Charles PD; Hauser RA; Sheean GL
    Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of dystonia of the lateral pterygoid muscle with botulinum toxin A.
    Mendes RA; Upton LG
    Br J Oral Maxillofac Surg; 2009 Sep; 47(6):481-3. PubMed ID: 18829144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of botulinum toxin treatment on previous primary headaches in patients with cranio-cervical dystonia].
    Pascual J
    Neurologia; 2004 Jun; 19(5):260-3. PubMed ID: 15150709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of treatment of spasmodic torticollis by neurovascular decompression, myotomy, and toxin type A: a comparative study].
    Sun KH; Lu YC; Hu GH; Luo C; Hou LJ; Chen JX; Zhou J
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):21-4. PubMed ID: 19489238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
    Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
    Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molding the sensory cortex: spatial acuity improves after botulinum toxin treatment for cervical dystonia.
    Walsh R; Hutchinson M
    Mov Disord; 2007 Dec; 22(16):2443-6. PubMed ID: 17960812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A therapy in a patient with cervical dystonia and amyotrophic lateral sclerosis.
    Singer C; Papapetropaulos S; Ayyar DR; Verma A
    Mov Disord; 2007 Jan; 22(2):289. PubMed ID: 17094101
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural history of posttraumatic cervical dystonia.
    Frei KP; Pathak M; Jenkins S; Truong DD
    Mov Disord; 2004 Dec; 19(12):1492-8. PubMed ID: 15390063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The entity of young onset primary cervical dystonia.
    Koukouni V; Martino D; Arabia G; Quinn NP; Bhatia KP
    Mov Disord; 2007 Apr; 22(6):843-7. PubMed ID: 17357144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for cervical dystonia.
    Med Lett Drugs Ther; 2001 Jul; 43(1109):63-4. PubMed ID: 11468603
    [No Abstract]   [Full Text] [Related]  

  • 19. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic and Functional Neurosurgery Resident Award: deep brain stimulation for generalized dystonia and spasmodic torticollis: rate and extent of postoperative improvement.
    Bittar RG; Yianni J; Wang S; Liu X; Nandi D; Joint C; Scott R; Bain PG; Gregory R; Stein J; Aziz TZ
    Clin Neurosurg; 2005; 52():379-83. PubMed ID: 16626097
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.